New JAMA study backs RSV vaccine safety during pregnancy Dr. Kamal Kant Kohli10 July 2024 4:00 AM ISTVaccinating mothers against respiratory syncytial virus (RSV) during late pregnancy to protect their newborns is not associated with an increased risk...
USFDA approves expanded age indication for GSK RSV vaccine Arexvy for adults aged 50-59 at increased risk Ruchika Sharma9 Jun 2024 10:00 AM ISTLondon: GSK plc has announced that the US Food and Drug Administration (FDA) has approved Arexvy (Respiratory Syncytial Virus (RSV) Vaccine,...
Moderna gets USFDA nod for mRNA RSV vaccine Ruchika Sharma2 Jun 2024 1:30 PM ISTCambridge: Moderna, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345), an mRNA respiratory...
Modify CT Protocol: CDSCO Panel Tells GSK on Respiratory Syncytial Virus(RSV) Vaccine Dr. Divya Colin24 March 2024 6:00 PM ISTNew Delhi: Reviewing the Phase III clinical trial protocol presented by the drug major GSK for the Respiratory Syncytial Virus (RSV) vaccine...
RSV vaccine Abrysvo is protective through a second year: Pfizer Ruchika Sharma3 March 2024 12:00 PM ISTNew York: Pfizer has said a single dose of its new respiratory syncytial virus (RSV) vaccine Abrysvo maintained its ability to protect against the...
GSK vaccine Arexvy accepted for regulatory review by EMA for adults aged 50-59 at increased risk for RSV Ruchika Sharma4 Feb 2024 10:00 AM ISTLondon: GSK plc has announced that the European Medicines Agency (EMA) has accepted the company's regulatory application to expand the use of its...
Moderna jumps on Oppenheimer upgrade, 2025 sales growth goal Ruchika Sharma3 Jan 2024 9:00 AM ISTAccording to Oppenheimer, Moderna could have five products on the market by 2026.
Pfizer maternal vaccine Abrysvo bags USFDA approval for RSV prevention in infants Ruchika Sharma22 Aug 2023 11:26 AM ISTNew York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO (Respiratory Syncytial Virus Vaccine),...
Pfizer sued by GSK for patent infringement over RSV vaccine Ruchika Sharma3 Aug 2023 12:30 PM ISTA GSK spokesperson said in a statement that intellectual property protections are the "foundation of research-based companies' ability to drive...
GSK gets CDSCO panel Nod for Phase III Extension safety follow-up study for trial of RSVPreF3 vaccine Dr. Divya Colin12 July 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted approval to the drug...
GSK gets European Commission nod for RSV vaccine Arexvy for older adults Ruchika Sharma7 Jun 2023 1:30 PM ISTRespiratory syncytial virus vaccine, adjuvanted, contains recombinant glycoprotein F stabilised in the prefusion conformation.
World's first RSV vaccine: GSK wins USFDA nod for Arexvy in older adults Ruchika Sharma4 May 2023 11:48 AM ISTRespiratory syncytial virus is a common contagious virus affecting the lungs and breathing passages.
